Peloton adds $22.2M to series D round

Peloton Therapeutics Inc. (Dallas, Texas) closed a new $22.2 million tranche of its series D financing, bringing the round's total to $74.6 million. The company raised $52.4 million in a September 2016 close (see BioCentury Extra, Sept. 15, 2016).

Foresite Capital Management, Remeditex, The Column Group, Tichenor Ventures, Topspin Fund and Nextech Invest participated in the first close. On Tuesday, Peloton CBO Michael Haller told BioCentury there were no new investors in the latest close...